Skip to main content

Table 2 Hemodynamic parameters

From: Effects on hemodynamics and gas exchange of omega-3 fatty acid-enriched lipid emulsion in acute respiratory distress syndrome (ARDS): a prospective, randomized, double-blind, parallel group study

 

T-0 h (baseline, preinfusion)

T-6 h

T-12 h (final infusion)

T-18 h (6 h postinfusion)

HR

    

A: n-3

91 ± 19

101 ± 20

100 ± 21

91 ± 25

B: LCT

95 ± 13

93 ± 12

95 ± 12

84 ± 16

CO

    

A: n-3

7.8 ± 2.8

8.4 ± 2.7

8.5 ± 2.7

7.8 ± 3

B: LCT

6.9 ± 1.3

7.3 ± 1.9

6.8 ± 1.6

6.1 ± 1.3

SAP

    

A: n-3

127 ± 19

113 ± 14

117 ± 15

131 ± 24

B: LCT

126 ± 9

126 ± 10

124 ± 14

121 ± 14

MPAP

    

A: n-3

26 ± 5

29 ± 4

28 ± 7

28 ± 6

B: LCT

30 ± 7

31 ± 7

31 ± 6

28 ± 7

PW

    

A: n-3

13 ± 4*

13 ± 2

14 ± 3

14 ± 4

B: LCT

16 ± 2

17 ± 2

17 ± 2

16 ± 2

PVR

    

A: n-3

162 ± 122

187 ± 98

155 ± 68

162 ± 92

B: LCT

147 ± 84

142 ± 102

138 ± 79

134 ± 77

SVR

    

A: n-3

822 ± 328

644 ± 194

629 ± 228

864 ± 376

B: LCT

863 ± 217

840 ± 274

884 ± 298

932 ± 238

DO 2

    

A: n-3

1074 ± 340

1171 ± 406

1174 ± 372

1066 ± 518

B: LCT

966 ± 224

1023 ± 330

936 ± 227

856 ± 225

VO 2 /DO 2

    

A: n-3

0.22 ± 0.04

0.24 ± 0.05

0.23 ± 0.04

0.25 ± 0.06

B: LCT

0.26 ± 0.05

0.25 ± 0.04

0.27 ± 0.03

0.25 ± 0.04

Q s /Q t

    

A: n-3

33 ± 10

31 ± 8

33 ± 11

28 ± 7

B: LCT

28 ± 11

27 ± 6

25 ± 8

25 ± 9

BT

    

A: n-3

38.1 ± 1

38 ± 0.9

38.1 ± 0.8

37.6 ± 1.2

B: LCT

37.6 ± 0.4

37.5 ± 0.6

37.6 ± 0.4

37.1 ± 1

  1. HR: heart rate, CO: cardiac output, SAP: systolic artery pressure, MPAP: mean pulmonary artery pressure, PW: pulmonary artery occlusion pressure, PVR: pulmonary vascular resistances, SVR: systemic vascular resistances DO2: oxygen delivery, Qs/Qt: venous admixture ratio, BT: body temperature.
  2. * p < 0.05 between baseline groups